How AI is Changing Clinical Development

Run Time

18 minutes
how-ai-changing-clinical-development

AI is no longer a peripheral tool in drug development. It is reshaping how trials are designed, run, and completed, and the pace of change is accelerating.

In this episode of the Drug Discovery World Podcast, Suzanne Caruso, President and General Manager of Clinical, Regulatory and Strategic Intelligence at Norstella, speaks with host Bruno Quinney about where AI is having the most material impact today.

Three areas stand out. Patient identification and matching, where AI is replacing passive recruitment with proactive targeting based on real-world data and protocol criteria. Study startup, where AI is compressing timelines that have historically stretched to six, nine, or twelve months. And synthetic control arms, where AI-matched real-world cohorts can replace placebo populations, potentially halving enrolment timelines and cutting the cost of large phase three studies.

Suzanne is direct about the limits too. Study startup remains far from the one-month ideal. Trust in AI outputs requires sourcing, oversight, and time. The human in the loop has not gone away.

The takeaway is practical: start using it, identify where it fits your workflows, and build from there.

Frequently asked questions

How is AI transforming clinical development?
AI is helping pharmaceutical companies improve clinical development by accelerating patient recruitment, optimizing study startup, enhancing trial monitoring and analyzing large volumes of real-world data. These capabilities enable sponsors to make faster, more informed decisions while improving trial efficiency and reducing development timelines.
How does AI improve patient recruitment for clinical trials?
AI analyzes clinical trial protocols alongside real-world patient data to identify eligible participants based on inclusion and exclusion criteria. This allows sponsors to proactively identify healthcare sites and patient populations, significantly reducing the time required to enroll clinical trials.
What role does real-world data play in AI-powered clinical trials?
Real-world data provides the foundation for AI to identify patients, optimize site selection, generate synthetic control arms and monitor clinical trials in real time. When combined with AI, real-world data enables more accurate insights and helps accelerate drug development.
Can AI replace human expertise in clinical development?
No. While AI automates many administrative and analytical tasks, human oversight remains essential. Clinical experts are needed to validate AI outputs, interpret results, ensure data quality and build trust through transparent, source-backed decision-making.

Norstella Brands